Inventor · disambiguated record
Irit Sagi
Also filed as: SAGI IRIT
23 granted patents·11 pending applications·138 citations·filing 2001–2025
94Inventor score
Top patents by PatentIndex Score
34 records- 0191US11382959B2Compositions for remodeling extracellular matrix and methods of use thereofNANOCELL LTD·Filed 2020·Granted Jul 12, 2022·4 cites·17 claims
- 0288US10722560B2Compositions for remodeling extracellular matrix and methods of use thereofNANOCELL LTD·Filed 2016·Granted Jul 28, 2020·5 cites·24 claims
- 0388US6744042B2Ion trappingYEDA RES & DEV·Filed 2001·Granted Jun 1, 2004·102 cites·7 claims
- 0485US12343386B2Compositions for remodeling extracellular matrix and methods of use thereofNANOCELL LTD·Filed 2023·Granted Jul 1, 2025·0 cites·10 claims
- 0583US9416195B2Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsYEDA RES & DEV·Filed 2013·Granted Aug 16, 2016·6 cites·5 claims
- 0681US7524938B2Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsYEDA RES & DEV·Filed 2004·Granted Apr 28, 2009·11 cites·6 claims
- 0778US11779636B2Compositions for remodeling extracellular matrix and methods of use thereofNANOCELL LTD·Filed 2022·Granted Oct 10, 2023·0 cites·12 claims
- 0875US8324355B2Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsSAGI IRIT·Filed 2008·Granted Dec 4, 2012·2 cites·3 claims
- 0974US8486653B2Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsSAGI IRIT·Filed 2012·Granted Jul 16, 2013·2 cites·6 claims
- 1073US10426821B2Variants of TACE pro-domain as TNF-A inhibitor and their medical useYEDA RES & DEV·Filed 2017·Granted Oct 1, 2019·1 cites·12 claims
- 1172US10933122B2Variants of TACE pro-domain as TNF-A inhibitor and their medical useYEDA RES & DEV·Filed 2019·Granted Mar 2, 2021·0 cites·11 claims
- 1269US9764008B2Variants of TACE pro-domain as TNF-A inhibitor and their medical useYEDA RES & DEV·Filed 2013·Granted Sep 19, 2017·1 cites·6 claims
- 1369US2024398906A1Propeptide of lysyl oxidase for treatment of cancerYEDA RES & DEV·Filed 2024·Application pending·0 cites
- 1469US2021162025A1Variants of tace pro-domain as tnf-a inhibitor and their medical useYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 1568US10610588B2Methods of preventing secondary infectionsYEDA RES & DEV·Filed 2016·Granted Apr 7, 2020·1 cites·4 claims
- 1667US2009208510A1Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsYEDA RES & DEV·Filed 2009·Application pending·0 cites
- 1766US8697078B2Antibodies that inhibit metalloproteinsSAGI IRIT·Filed 2011·Granted Apr 15, 2014·1 cites·16 claims
- 1866US2024166768A1Anti-matrix metalloproteinase-14 antibodies for the treatment of cancerYEDA RES & DEV·Filed 2024·Application pending·0 cites
- 1965US2014370031A1Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsYEDA RES & DEV·Filed 2014·Application pending·0 cites
- 2064US8999332B2Regulators of MMP-9 and uses thereofYEDA RES & DEV·Filed 2013·Granted Apr 7, 2015·1 cites·2 claims
- 2162US10040868B2Antibodies targeted against LOXL-2 for the treatment of collagen-associated pathologiesYEDA RES & DEV·Filed 2014·Granted Aug 7, 2018·1 cites·11 claims
- 2262US2011052572A1Regulators of mmp-9 and uses therofYEDA RES & DEV·Filed 2008·Application pending·0 cites
- 2359US11400156B2Methods of preventing secondary infectionsYEDA RES & DEV·Filed 2020·Granted Aug 2, 2022·0 cites·10 claims
- 2459US9902783B2Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsYEDA RES & DEV·Filed 2016·Granted Feb 27, 2018·0 cites·5 claims
- 2559US8841108B2Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsSAGI IRIT·Filed 2011·Granted Sep 23, 2014·0 cites·6 claims
- 2659US2018134808A1Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsYEDA RES & DEV·Filed 2018·Application pending·0 cites
- 2758US12291578B2Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereofYEDA RES & DEV·Filed 2020·Granted May 6, 2025·0 cites·17 claims
- 2858US2022049236A1Compositions comprising the propeptide of lysyl oxidase and uses thereofYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 2954US9217041B2Antibodies that inhibit metalloproteinsYEDA RES & DEV·Filed 2014·Granted Dec 22, 2015·0 cites·13 claims
- 3053US2025206846A1Anti-klk4 antibodies and uses thereofYEDA RES & DEV·Filed 2025·Application pending·0 cites
- 3144US2025177497A1Novel bacteria-based delivery system for tace (adam17) selective biological inhibitorYEDA RES & DEV·Filed 2025·Application pending·0 cites
- 3241US10066024B2Methods of generating antibodies to metalloenzymesSAGI IRIT·Filed 2011·Granted Sep 4, 2018·0 cites·4 claims
- 3338US2015158953A1Regulators of mmp-9 and uses thereofYEDA RES & DEV·Filed 2015·Application pending·0 cites
- 3427US7558679B2System and method for irradiating a sampleYEDA RES & DEV·Filed 2002·Granted Jul 7, 2009·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Irit Sagi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →